FindTrial
Sign In

Genetics and genome sequencing study of pelvic organ prolapse patients

Genetics and genome sequencing study of pelvic organ prolapse patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000034916
Enrollment
Unknown
Registered
2020-07-24
Start date
2020-07-27
Completion date
Unknown
Last updated
2020-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic organ prolapse

Interventions

Prolapse case:Not applicable
Control:Not applicable

Sponsors

None listed

Eligibility

Sex/Gender
Male
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Subjects will be those planning for surgical treatment for POP, and control subjects will be those planning for hysterectomy for non-prolapse and benign gynaecological diseases; 2. Patient age 18 year old or above; 3. Willing to give written consent.

Exclusion criteria

Exclusion criteria: Patient refuses to participate in the study

Design outcomes

Primary

MeasureTime frame
Genetics and genome sequencing of patient associated with pelvic organ prolapse;—

Secondary

MeasureTime frame
Genetics and genomic of patients with recurrence of pelvic organ prolapse at 3 years post-operation;—

Countries

China

Contacts

Public ContactChoy Richard Kwong Wai

The Chinese University of Hong Kong

richardchoy@cuhk.edu.hk+852 35053099

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026